Connection

W. Garvey to Canagliflozin

This is a "connection" page, showing publications W. Garvey has written about Canagliflozin.
Connection Strength

0.810
  1. Effects of canagliflozin versus glimepiride on adipokines and inflammatory biomarkers in type 2 diabetes. Metabolism. 2018 08; 85:32-37.
    View in: PubMed
    Score: 0.622
  2. Canagliflozin extends life span in genetically heterogeneous male but not female mice. JCI Insight. 2020 11 05; 5(21).
    View in: PubMed
    Score: 0.188
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.